Yoga guru Ramdev on Friday released a research paper by his Haridwar-based Patanjali Research Institute on the “first evidence-based ayurvedic medicine” against the coronavirus disease (Covid-19), Coronil.
The event was also attended by Union health minister Harsh Vardhan and Union transport minister Nitin Gadkari.
Releasing the research paper, Ramdev emphasised on its certification from the World Health Organization (WHO) and said the research paper was to satisfy those who had earlier questioned the scientific relevance of the medicine.
1st evidence-based medicine for Covid-19 (CoPP-WHO GMP certified)
With the guidance of Pujya Swami Ji & Pujya Acharya Ji & the hard work of scientists at Patanjali Research Institute, the efforts have been successful.#Patanjalis_EvidenceBased_Medicine4Corona #PatanjaliCoronil pic.twitter.com/L4xdZTajWW— Patanjali Ayurved (@PypAyurved) February 19, 2021
“Coronil has received the Certificate of Pharmaceutical Product (CoPP) from the Ayush section of Central Drugs Standard Control Organisation as per the WHO certification scheme,” a statement issued by Patanjali said.
Under CoPP, Coronil can be exported to 158 countries.
In June 2020, Ramdev’s Patanjali had brought out its medicine against Covid-19, which was under scrutiny due to lack of scientific evidence and trials that could determine its efficacy in combating the deadly virus. Coronil, which was first advertised as a cure for the coronavirus, was later licensed as an “immunity booster” amid the controversy.
During the event on Friday, Ramdev said the aim of the institute was to accredit the ancient medical science of India globally by providing scientific evidence and fulfill the “Aatmanirbhar Bharat” vision in healthcare.
Patanjali Research Institute’s scientific research and success on the first evidence based corona medicine will benefit 158 countries of the world#Patanjalis_EvidenceBased_Medicine4Corona #PatanjaliCoronil pic.twitter.com/uH3JbjXyYy
— Patanjali Dairy (@PatanjaliDairy) February 19, 2021
“Patanjali Research Institute’s scientific research and success on the first evidence-based corona medicine will benefit 158 countries of the world,” the company’s dairy arm tweeted.
Citing a conversation between WHO’s director general Tedros Adhanom Ghebreyesus with Prime Minister Narendra Modi, the union health minister reportedly said the global body is impressed with India’s work in the field and would want to establish a global centre for Ayurveda in India.
